Research progress on treatment-associated pneumonitis in lung cancer patients undergoing radiotherapy and immunotherapy.

IF 2.6 4区医学 Q2 ONCOLOGY

Future oncology Pub Date : 2025-08-01 Epub Date: 2025-07-08 DOI:10.1080/14796694.2025.2525067

Caixun Zhang, Youjia Wang, Hanguang Ruan, Vivek Verma, Weimin Xu, Guang Han

引用次数: 0

Abstract

Radiotherapy and immunotherapy - both important facets of modern cancer treatment - provide therapeutic benefits, but also raise concerns from potential concomitant adverse effects. One such adverse event, treatment-associated pneumonitis (TAP), can cause profound changes in quality of life of patients with thoracic malignancies. The aim of this review is to elucidate the pathogenesis, incidence, risk factors, differential diagnosis, and management of pneumonitis induced by the combination of radiotherapy and immunotherapy for lung cancer.

查看原文本刊更多论文

肺癌放疗和免疫治疗患者治疗相关性肺炎的研究进展。

放射治疗和免疫治疗——这两个现代癌症治疗的重要方面——提供了治疗益处，但也引起了人们对潜在的伴随副作用的担忧。其中一个不良事件，治疗相关性肺炎（TAP），可导致胸部恶性肿瘤患者生活质量的深刻变化。本文就肺癌放射与免疫联合治疗致肺炎的发病机制、发病率、危险因素、鉴别诊断及治疗进行综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future oncology ONCOLOGY-

CiteScore

5.40

自引率

3.00%

发文量

335

审稿时长

4-8 weeks

期刊介绍： Future Oncology (ISSN 1479-6694) provides a forum for a new era of cancer care. The journal focuses on the most important advances and highlights their relevance in the clinical setting. Furthermore, Future Oncology delivers essential information in concise, at-a-glance article formats - vital in delivering information to an increasingly time-constrained community. The journal takes a forward-looking stance toward the scientific and clinical issues, together with the economic and policy issues that confront us in this new era of cancer care. The journal includes literature awareness such as the latest developments in radiotherapy and immunotherapy, concise commentary and analysis, and full review articles all of which provide key findings, translational to the clinical setting.